with s. c. johnson & son . johnson & johnson j & j headquarters at one johnson & johnson plaza in new brunswick new jersey type public traded as nyse jnj dow jones industrial average component s & p 500 component industry medical equipment pharmaceutical founded january 1886 ; 130 years ago 1886 01 new brunswick new jersey u.s. founders robert wood johnson i james wood johnson edward mead johnson headquarters one johnson & johnson plaza new brunswick new jersey u.s. area served worldwide key people alex gorsky chairman and ceo products see list of johnson & johnson products revenue us 70.07 billion 2015 1 operating income us 19.19 billion 2015 1 net income us 15.40 billion 2015 1 total assets us 133.41 billion 2015 1 total equity us 71.15 billion 2015 1 number of employees 127 100 2015 1 subsidiaries mcneil consumer healthcare vistakon 2 neutrogena depuy website jnj.com johnson & johnson is an american multinational medical devices pharmaceutical and consumer packaged goods manufacturer founded in 1886 . its common stock is a component of the dow jones industrial average and the company is listed among the fortune 500 . johnson & johnson is headquartered in new brunswick new jersey directly adjacent to the campus of rutgers university the consumer division being located in skillman new jersey . the corporation includes some 250 subsidiary companies with operations in 60 countries and products sold in over 175 countries . johnson & johnson had worldwide sales of 70.1 billion during calendar year 2015 . 3 johnson & johnson s brands include numerous household names of medications and first aid supplies . among its well known consumer products are the band aid brand line of bandages tylenol medications johnson s baby products neutrogena skin and beauty products clean & clear facial wash and acuvue contact lenses . contents 1 history 1.1 foundation and early history 1.2 1959 mcneil consumer healthcare 1.3 1959 cilag 1.4 1961 janssen pharmaceuticals 1.5 1998 depuy 1.6 1999 janssen biotech inc. 1.7 ethicon inc 1.7.1 ethicon endo surgery inc. 1.8 2010 crucell 1.9 structure 2 corporate governance 3 jnj headquarters and the new brunswick gentrification 3.1 chairmen 4 products 4.1 pharmaceuticals 4.2 medical devices 4.3 consumer health 5 environmental record 6 recalls and litigation 6.1 1982 chicago tylenol murders 6.2 2010 children s product recall 6.3 2010 hip replacement recall 6.4 2010 tylenol recall 6.5 shareholders lawsuit 6.6 illegal marketing of risperdal 7 foreign bribery 7.1 use of the red cross symbol 7.2 boston scientific lawsuits 7.3 patent infringement case against abbott 7.4 baby powder 8 products 9 see also 10 references 11 external links history edit johnson & johnson operates over 250 companies in what is termed the johnson & johnson family of companies . 4 the company operates in three broad divisions ; consumer healthcare medical devices and pharmaceuticals . johnson & johnson family of companies consumer healthcare 5 medical devices 6 pharmaceuticals 7 baby care skin & hair care wound care and topicals oral health care women s health mcneil consumer healthcare over the counter medicines nutritionals advanced sterilization products animas corporation biosense webster depuy synthes companies of johnson & johnson ethicon inc. janssen diagnostics bvba johnson & johnson vision care inc. lifescan inc. mentor janssen janssen r & d llc janssen healthcare innovation janssen pharmaceuticals inc janssen diagnostics janssen therapeutics janssen scientific affairs mcneil ppc inc foundation and early history edit robert wood johnson inspired by a speech by antiseptic advocate joseph lister robert wood johnson joined his brothers james wood johnson and edward mead johnson to create a line of ready to use surgical dressings in 1885 . the company produced its first products in 1886 and incorporated in 1887 . robert wood johnson served as the first president of the company . he worked to improve sanitation practices in the nineteenth century and lent his name to a hospital in new brunswick new jersey . upon his death in 1910 he was succeeded in the presidency by his brother james wood johnson until 1932 and then by his son robert wood johnson ii . robert wood johnson s granddaughter mary lea johnson richards was the first baby to appear on a johnson & johnson baby powder label . 8 9 10 his great grandson jamie johnson made a documentary called born rich about the experience of growing up as the heir to one of the world s greatest fortunes . 1959 mcneil consumer healthcare edit mcneil consumer healthcare was founded on march 16 1879 by 23 year old robert mcneil . in 1904 one of mcneil s sons robert lincoln mcneil became part of the company and together they created mcneil laboratories in 1933 . the company focused on direct marketing of prescription drugs to hospitals pharmacists and doctors . development of acetaminophen began under the leadership of robert l. mcneil jr. who later served as the firm s chairman . 11 in 1959 johnson & johnson acquired mcneil laboratories and a year later the company was able to sell tylenol for the first time ever without a prescription . in 1977 two subsidiary companies were created ; mcneil medicals products and mcneil consumer products company also known as mcneil consumer healthcare . the focus of mcneil medicals products is to market prescription drugs . in 1993 mcneil medicals products merged with the ortho pharmaceutical to form ortho mcneil pharmaceutical . in 2001 mcneil consumer healthcare changed its name to mcneil consumer & specialty medicals products . however it was later changed to mcneil consumer healthcare . the company markets over the counter and prescription medicals products including complete lines of tylenol and motrin ib ibuprofen products for adults and children . 1959 cilag edit in 1933 swiss chemist bernhard joos set up a small research laboratory in schaffhausen switzerland . this set the basis for the founding of chemische industrie labor ag chemical industry laboratory ag or cilag on 12 may 1936 . in 1959 cilag joined the johnson & johnson family of companies . in the early nineties the marketing organizations of cilag and janssen pharmaceutica were joined to form janssen cilag . the non marketing activities of both companies still operate under their original name . cilag continues to have operations under the cilag name in switzerland ranging from research and development through manufacturing and international services . in august 2014 cilag acquired covagen a biopharmaceutical company which specialises in the development of multi specific protein based therapeutics . as part of the acquisition cilag wll gain access to covagen s lead drug candidate cova 322 a bi specific anti tumor necrosis factor tnf alpha anti interleukin il 17a fynomab is in a phase ib study for psoriasis . 12 1961 janssen pharmaceuticals edit janssen pharmaceuticals can be traced back to 1933 . in 1933 constant janssen the father of paul janssen acquired the right to distribute the pharmaceutical products of richter a hungarian pharmaceutical company for belgium the netherlands and belgian congo . on 23 october 1934 he founded the n.v. produkten richter in turnhout . after the second world war the name for the company products was changed to eupharma although the company name richter would remain until 1956 . 13 paul janssen founded his own research laboratory in 1953 on the third floor of the building in the statiestraat still within the richter eurpharma company of his father . on 5 april 1956 the name of the company was changed to nv laboratoria pharmaceutica c. janssen named after constant janssen . on 2 may 1958 the research department in beerse became a separate legal entity the n.v. research laboratorium c. janssen . on 24 october 1961 the company was acquired by the american corporation johnson & johnson . on 10 february 1964 the name was changed to janssen pharmaceutica n.v. between 1990 and 2004 janssen pharmaceuticals expanded worldwide with the company grew in size to approximately 28000 employees worldwide . in 1999 clinical research and non clinical development become a global organization within johnson & johnson . in 2001 part of the research activities was transferred to the united states with the reorganization of research activities in the johnson & johnson pharmaceutical research and development organization . the research activities of the janssen research foundation and the r.w. johnson pharmaceutical research institute were merged into the new global research organization . on 27 october 2004 the paul janssen research center for discovery research was inaugurated . in august 2013 the company acquired aragon pharmaceuticals inc. . in november 2014 the company acquired alios biopharma inc. for 1.75 billion . as a result of the purchase alios was incorporated into the infectious diseases therapeutic area of the janssen pharmaceutical companies of johnson & johnson . 14 in march 2015 janssen licensed tipofarnib a farnesyl transferase inhibitor to kura oncology who will assume sole responsibility for developing and commercialising the anti cancer drug . 15 later in the same month the company announced that galapagos pharma and regained the rights to the anti inflammatory drug candidate glpg1690 as well as two other compounds including glpg1205 a first in class inhibitor of gpr84 . 16 finally in march the company acquired xo1 limited 17 in november 2015 the company acquired novira therapeutics inc. gaining the lead candidate nvr 3 778 . 18 1998 depuy edit depuy was acquired by j & j in 1998 rolling it into the johnson & johnson medical devices group . on june 14 2012 johnson and johnson completed the acquisition of synthes for 19.7 billion 19 which was then integrated with the depuy franchise to establish the depuy synthes companies of johnson & johnson which includes ; codman & shurteff inc. depuy mitek inc. depuy orthopaedics inc. and depuy spine inc. 1999 janssen biotech inc. edit janssen biotech inc. formerly known as centocor biotech inc. is a biotechnology company that was founded in philadelphia in 1979 . in 1982 centocor transitioned into a publicly traded company . in 1999 centocor became a wholly owned subsidiary of johnson & johnson . since the acquisition janssen biotech increased its annual sales from 500 million to more than 2 billion . during the same period research and development investment increased from 75 million to more than 300 million . in 2008 centocor inc. and ortho biotech inc. merged to form centocor ortho biotech inc. in june 2010 centocor ortho biotech acquired respivert a privately held drug discovery company focused on developing small molecule inhaled therapies for the treatment of pulmonary diseases . 20 in june 2011 centocor ortho biotech changed its name to janssen biotech inc. as part of a global effort to unite the janssen pharmaceutical companies around the world under a common identity . in december 2014 the company announced it would co develop macrogenics cancer drug candidate mgd011 which targets both cd19 and cd3 proteins in treating b cell malignant tumours . this could net macrogenics up to 700 million . 21 in january 2015 the company announced it will utilise isis pharmaceuticals rna targeting technology to discover and develop antisense drugs targeting autoimmune disorders of the gastrointestinal tract with the partnership potentially generating up to 835 million for isis . 22 ethicon inc edit in 1915 george f. merson opened a facility in edinburgh for the manufacturing packaging and sterilising of catgut silk and nylon sutures . johnson & johnson acquired mr. merson s company in 1947 and this was renamed ethicon suture laboratories . 23 in 1953 this became ethicon inc. 24 in 1992 ethicon was restructured and ethicon endo surgery inc. became a separate corporate entity . during the 1990s ethicon diversified into new and advanced products and technologies and formed four different companies under the ethicon umbrella each of which specialize in different products . in 2008 j & j announced it would acquire mentor corporation for 1 billion and merge its operations into ethicon . 25 in march 2016 j & js ethicon business unit announced it would acquire